World Orphan Drug Congress, Europe

October 25, 2021

Slated for November 15 to 18, 2021, the World Orphan Drug Congress presents one of Europe’s most exciting events offering conference topics in cell and gene therapy, genetic testing, gene editing, partnering and investment, global

Hello, Pills!

September 7, 2020

With the recent approval and commercial launch of MYCAPSSA®, Chiasma delivers the first and only oral somatostatin analog to treat acromegaly. The research showed 58% of patients maintained normal IGF-1 levels with the new oral

More news on Isturisa for Cushing’s

June 10, 2020

In a recent press release, Recordati Rare Diseases Inc., a biopharmaceutical company committed to developing therapies for rare disease communities of the United States, announced the full availability of Isturisa® for the treatment of adult